Welcome to the e-CCO Library!

P763: Fucosyltransferase 2 non-secretor status in Crohn's disease: a prospective observational analysis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Battat R.*1,2, Kopylov U.3, Afif W.1, Bessissow T.1, Byer J.4, Dionne S.1, Zelikovic E.4, Seidman E.1, Bitton A.1

Created: Wednesday, 20 February 2019, 10:36 AM
P763: Quality of life in Paediatric inflammatory bowel disease Patient: How well do we understand patients?
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Kim, S. Park, Y. Kang, H. Koh

Created: Thursday, 21 February 2019, 9:14 AM
P763: Role of quality of life in patients with Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Kaltenbach, T.(1)*;Schulte, L.A.(1);Kranzeder, A.(2);Klaus, J.(1);Sularz, M.(1);
Created: Friday, 14 July 2023, 11:12 AM
P764 Phenotypic analysis of patients with inflammatory bowel disease: 23 year data of a centre in a South American country
Year: 2020
Source:

ECCO'20 Vienna

Authors:

C.C. Páez Cancelado1, R. García Duperly2, J. Park3, R. López Panqueva4, E.E. Londoño Schimmer2, A.M. Rey Rubiano5, J.E. Padrón Mercado2, M. Mejía Arango4, A. Gómez Aldana1, R.J. Vallejo Madroñero1, B. Mendoza De Molano6

Created: Thursday, 30 January 2020, 10:12 AM
P764: Drug level thresholds in patients with Crohn’s disease on dose-intensified anti-TNF therapy predict intestinal wall healing for infliximab but not adalimumab
Year: 2018
Source: ECCO '18 Vienna
Authors:

R. Little*, H. Su, A. Friedman, S. Williams, P. Gibson, M. Ward, K. Taylor, M. Sparrow

Created: Thursday, 21 February 2019, 9:14 AM
P764: Effectiveness and safety of COVID-19 Vaccine among Patients with Inflammatory Bowel Disease: A medical center hospital-based study in central Taiwan
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Wu, Y.H.(1)*;Chou, J.W.(2);Huang, P.J.(1);Wang, C.P.(1);Cheng, K.S.(1);
Created: Friday, 14 July 2023, 11:12 AM
P764: Prevalence of Autoimmune diseases among first- and second-degree relatives of patients with inflammatory bowel diseases. A case–control survey in Israel
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

T. Khoury*1, A. Mari2, L. Mhamed3, M. Mahamid4

Created: Friday, 22 February 2019, 9:41 AM
P764: Response to thiopurines is independent of ATG16L1 genotype
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Verstockt B.*1,2, Matthias A.T.3, Strongili K.3, Cleynen I.4, Parkes M.3

Created: Wednesday, 20 February 2019, 10:36 AM
P765 Fatigue as one of the most important symptoms in adult patients with inflammatory bowel disease: Croatian tertiary centre pilot study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

P. Ćaćić, V. Tomašić, D. Kralj, A. Bišćanin, Z. Dorosulić, I. Lerotić, D. Ogresta, J. Forgač, D. Hrabar

Created: Thursday, 30 January 2020, 10:12 AM
P765: A description of inflammatory bowel disease patients’ beliefs in their medications, in comparison with patients with other chronic conditions
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

I. Marín-Jiménez*1, D. Orozco-Beltrán2, J. Toro3, M. J. Galindo4, B. Juliá5, L. Cea-Calvo6

Created: Friday, 22 February 2019, 9:41 AM
P765: Role of C-reactive protein kinetics after surgery for Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Carvello*, F. Di Candido, G. Fiorino, S. Danese, A. Spinelli

Created: Thursday, 21 February 2019, 9:14 AM
P765: Tolerating infliximab therapeutic drug monitoring without anti-drug antibodies – an argument for drug intolerant assays?
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Carlson, S.(1);Evgeniou, V.(1)*;Kok, K.(1);
Created: Friday, 14 July 2023, 11:12 AM
P765: Transcriptome of intestinal epithelial barrier genes in the colonic mucosa from patients with ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Fonseca Camarillo G., Iturriaga Goyon E., Yamamoto Furusho J.K.

Created: Wednesday, 20 February 2019, 10:36 AM
P766 ABO blood groups and ulcerative colitis: A hospital-based study in central Taiwan
Year: 2020
Source:

ECCO'20 Vienna

Authors:

H.C. Lai1, J.W. Chou2, K.S. Cheng2, Y.H. Wu2, Y.Y. Tsai3, T.W. Chen4

Created: Thursday, 30 January 2020, 10:12 AM
P766: Combination therapy of fresh fecal microbial transplantation and antibiotics for ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ishikawa D., Takahashi M., Haga K., Shibuya T., Osada T., Watanabe S.

Created: Wednesday, 20 February 2019, 10:36 AM
P766: Practical application of evidence-based dietary therapy into inflammatory bowel disease care shows high patient satisfaction, compliance, and efficacy. The Delectable Program
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Russell, E.(1,2);Trakman, G.(1,2,3);Hamilton, A.L.(1,2);Wilson-O'Brien, A.(1,2);Hendricks, N.(4);Simmance, N.(4);Thompson, E.(4);Niewiadomski, O.(1)*;Kamm, M.(1,2);
Created: Friday, 14 July 2023, 11:12 AM
P766: Quantum Blue® fCAL extended POC user performance evaluation
Year: 2018
Source: ECCO '18 Vienna
Authors:

B. Fellay1, M. Drzewicka2, E. Burri3, M.-E. Ueberschlag4, A. Ritz4, J. Wieland4, M. Schneider4*

Created: Thursday, 21 February 2019, 9:14 AM
P767 Prevalence and incidence rates of inflammatory bowel disease among First Nations: Population-based evidence from Saskatchewan, Canada
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J.N. Peña-Sánchez1, D. Jennings1, J.A. Osei1, M. Andkhoie2, C. Brass3, G. Bukassa Kazadi4, S. Fowler5, M. Johnson-Jennings6, X. Lu7, J.D. Marques Santos1, L. Porter8, R. Porter9, C.L. Quintin10, R. Sanderson11, U. Teucher12, IBD Among Indigenous Peoples Research Group

Created: Thursday, 30 January 2020, 10:12 AM
P767: Intestinal ultrasonography predicts short term clinical remission in patients with moderate-to-severe ulcerative colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Zorzi, F.(1);De Cristofaro, E.(1);Abreu, M.T.(2);Montesano, L.(1);Cuccagna, E.(1);Essofi, S.(1);Biancone, L.(1);Monteleone , G.(1);Calabrese, E.(1)*;
Created: Friday, 14 July 2023, 11:12 AM